A role of PGC1α in preventing melanoma metastasis was shown with treatment with a BRAF inhibitor, which upregulated PGC1α and its downstream target DNA-binding protein inhibitor-2 (ID-2), which in turn led to suppression of metastasis-related genes [41]. The gene discussed is PPARGC1A; the disease is melanoma.